Home › Leiomyosarcoma › Massachusetts › Boston
Leiomyosarcoma clinical trials in Boston, MA
5 studies for Leiomyosarcoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
RecruitingPhase 3
- Dana-Farber/Harvard Cancer Center, Boston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Dana Farber Cancer Institute, Boston
Metastatic Leiomyosarcoma Biomarker Protocol
RecruitingObservational study
- Dana- Farber, Boston
Leiomyosarcoma trials in other cities
- Houston, TX7 studies
- Santa Monica, CA4 studies
- Chicago, IL4 studies
- Columbus, OH3 studies
- Ann Arbor, MI3 studies
- Rochester, MN3 studies
- Nashville, TN3 studies
- New York City, NY3 studies
- Queens, NY3 studies
- St. Louis, MO3 studies
- Aurora, CO3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Ovarian Cancer62 studies
- Lung Cancer62 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.